Supriya Lifescience Limited (SLL) is an API manufacturer (Active Pharmaceutical Ingredients) with a portfolio of 38 APIs and is focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.

In Fiscal 2021, the company’s products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.

Supriya Lifescience has a modern manufacturing facility in Maharashtra spread across 23,806 sq. mts, having a reactor capacity of 547 KL/ day including 7 clean rooms. The company has also acquired a plot of land, admeasuring 12,551 sq. mt, near the present manufacturing facility, to expand its manufacturing infrastructure. The company’s manufacturing facility has received approvals from USFDA, EDQM TGA-Australia, KFDA-Korea, PMDA Japan, NMPA (previously known as SFDA)- China, Health Canada, in relation to API products being exported to the relevant jurisdictions by the company.

Supriya Lifescience Limited – IPO Timetable

Price band of the book built issue has been fixed at ₹265 to ₹274 per equity share. The IPO market lot size is 54 shares. A retail-individual investor can apply for up to 13 lots (702 shares or ₹192,348).

The Grey Market Premium (GMP ) is being quoted at around 290 ₹ , so assuming you get the shares at the upper band of ₹ 274 , the listing is going to be at more than double that amount at around 274+290 = ₹ 564 (105.84%)

What this means is that you get to double your investment in less than 15 days (provided your bid is accepted :))

So get on and apply for Listing Gain.

The post Supriya Lifescience – Another attractive IPO with a positive outlook first appeared on FINCHARGE.

The company aims to raise ₹588.22 crore from its book built issue ( ₹240 crore from fresh issue and ₹348.22 crore through Offer for Sale – OFS)

Data Patterns IPO price band is fixed at ₹555 to ₹585 per equity share

The IPO is opening for subscription from today (14th Dec.) and will remain open for bidding till 16th December 2021.

One can apply for minimum one lot and maximum 13 lots. This translates to a minimum investment for the IPO at ₹14,625 ( ₹585 x 25) whereas maximum investment allowed is ₹1,90,125 [( ₹585 x 25) x 13]. The tentative date for announcement of share allocation is 21st December 2021. Initiation of refunds is expected to begin on 22nd December 2021 while credit of shares in the Demat Account of allottees is likely on 23rd December 2021.

What does GMP indicate

We have already seen how GMP is a good indicator of the listing price. In case of Data Patterns, the GMP on day 1 of the IPO offer is said to be ₹610 . This means that the grey market is expecting shares of Data Patterns to list at a price of around ₹1195 ( ₹585 + ₹610). That’s a cool profit that one can make by investing in this IPO going by the GMP indications.

The post Data Patterns – Another good IPO opportunity first appeared on FINCHARGE.

The public issue of Medplus Health Services Limited is opening today and it will remain available for bidding till 15th December 2021. Price band of the book built issue has been fixed at ₹780 to ₹796 per equity share and the company aims to raise ₹1,398.30 crore from this public offer ( ₹600 crore from fresh issue and ₹798.30 crore through Offer for Sale or OFS). Shares of Medplus Health Services are available at a premium of ₹280 in the grey market today. That means grey market is expecting this public issue to list at around ₹1076 ( ₹796 + ₹280), according to market players.

The post MedPlus IPO expected to give good returns first appeared on FINCHARGE.

The post Vow!Another IPO blockbuster – Tega Industries lists at 68% premium first appeared on FINCHARGE.

So what would be a good indicator to help you pick the right IPOs? There is no better way to judge a stock than by looking at its fundamentals – the profitability, market share, competitor analysis etc. But a quick indicator to the IPO listing would be through the GMP – Grey Market Premium- a term used in the IPO market to check what is the estimated price the IPO might list on.

The grey market is unofficial but it helps investors look at the likely market listing price of an IPO. It reflects the broad market sentiment about the particular stokc. The grey market works before the IPO listing and during the days from the IPO start date to the allotment date. The grey market premium indicates how the IPO might react on a listing day with an estimated price. If the company comes up with an IPO of ₹500 and the grey market premium is around ₹100 then we can assume that the IPO might list at around ₹600 on its listing day. The GMP varies every day in the run up to the date of application, and is an indicator of the likely range of the listing price.

Table showing the offer price, GMP and Listing price

The post Use GMP to invest in the right IPOs first appeared on FINCHARGE.